Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance

Nitsupa Wattanachai, Wichittra Tassaneeyakul, Andrew Rowland, David Elliot, Kushari Bowalgaha Ralalage, Kathleen Knights, John Miners

    Research output: Contribution to journalArticlepeer-review

    35 Citations (Scopus)

    Abstract

    Long-chain unsaturated fatty acids inhibit several cytochrome P450 and UDP-glucuronosyltransferase (UGT) enzymes involved in drug metabolism, including CYP2C8, CYP2C9, UGT1A9, UGT2B4, and UGT2B7. Bovine serum albumin (BSA) enhances these cytochrome P450 and UGT activities by sequestering fatty acids that are released from membranes, especially with human liver microsomes (HLM) as the enzyme source. Here, we report the effects of BSA on CYP1A2-catalyzed phenacetin (PHEN) O-deethylation and lidocaine (LID) N-deethylation using HLM and Escherichia coli-expressed recombinant human CYP1A2 (rCYP1A2) as the enzyme sources. BSA (2% w/v) reduced (p < 0.05) the K m values of the high-affinity components of human liver microsomal PHEN and LID deethylation by approximately 70%, without affecting V max . The K m (or S 50 ) values for PHEN and LID deethylation by rCYP1A2 were reduced to a similar extent. A fatty acid mixture, comprising 3 μM concentrations each of oleic acid and linoleic acid plus 1.5 μM arachidonic acid, doubled the K m value for PHEN O-deethylation by rCYP1A2. Inhibition was reversed by the addition of BSA. Ki values for the individual fatty acids ranged from 4.7 to 16.7 μM. Single-point in vitro-in vivo extrapolation (IV-IVE) based on the human liver microsomal kinetic parameters obtained in the presence, but not absence, of BSA predicted in vivo hepatic clearances of PHEN O-deethylation and LID N-deethylation that were comparable to values reported in humans, although in vivo intrinsic clearances were underpredicted. Prediction of the in vivo clearances of the CYP1A2 substrates observed here represents an improvement on other experimental systems used for IV-IVE.

    Original languageEnglish
    Pages (from-to)982-989
    Number of pages8
    JournalDrug Metabolism and Disposition
    Volume40
    Issue number5
    DOIs
    Publication statusPublished - May 2012

    Fingerprint

    Dive into the research topics of 'Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance'. Together they form a unique fingerprint.

    Cite this